Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-24-013251
Filing Date
2024-04-25
Accepted
2024-04-25 16:36:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A pbla20240424_defa14a.htm DEFA14A 42705
2 EXHIBIT 3.1 ex_660171.htm EX-3.1 17037
3 EXHIBIT 10.1 ex_660172.htm EX-10.1 41018
  Complete submission text file 0001437749-24-013251.txt   102042
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39468 | Film No.: 24877001
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)